Relevant bibliographies by topics / Plasma glycan

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers

Academic literature on the topic 'Plasma glycan'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Plasma glycan.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Plasma glycan"

Walker, Sierra A., Jesús S. Aguilar Díaz De león, Sara Busatto, Gregory A. Wurtz, Abba C. Zubair, Chad R. Borges, and Joy Wolfram. "Glycan Node Analysis of Plasma-Derived Extracellular Vesicles." Cells 9, no. 9 (August 22, 2020): 1946. http://dx.doi.org/10.3390/cells9091946.

Full text

Abstract:

Blood plasma is a readily accessible source of extracellular vesicles (EVs), i.e., cell-secreted nanosized carriers that contain various biomolecules, including glycans. Previous studies have demonstrated that glycans play a major role in physiological and pathological processes, and certain plasma glycans have been associated with disease conditions. However, glycome studies have been limited by a lack of analytical techniques with the throughput capacity necessary to study hundreds of clinical samples. This study is the first to characterize the EV plasma glycome based on all major glycan classes. The results based on glycan node analysis revealed, as expected, that plasma-derived EVs have distinct glycan features from donor-matched whole plasma. Specifically, glycan nodes corresponding to those observed in chondroitin sulfate, dermatan sulfate, type I keratan sulfate, and type II keratan sulfate were enriched on EVs. The identification of specific differences in glycan features in plasma vs. plasma-derived EVs is relevant for understanding the physiological role of EVs and as a reference for future diagnostic studies. Additionally, the results indicate that EV glycan nodes do not substantially differ among a small set of healthy donors. These results lay the framework for the further evaluation of all EV glycan classes as diagnostic markers, therapeutic targets, and biologically active components in health and disease.

APA, Harvard, Vancouver, ISO, and other styles

Wopereis, Suzan, Stephanie Grünewald, Karin MLC Huijben, Éva Morava, Rosella Mollicone, Baziel GM van Engelen, Dirk J. Lefeber, and Ron A. Wevers. "Transferrin and Apolipoprotein C-III Isofocusing Are Complementary in the Diagnosis of N- and O-Glycan Biosynthesis Defects." Clinical Chemistry 53, no. 2 (February 1, 2007): 180–87. http://dx.doi.org/10.1373/clinchem.2006.073940.

Full text

Abstract:

Abstract Background: Apolipoprotein C-III (apoC-III) isoelectric focusing (IEF) can be used to detect abnormalities in the biosynthesis of core 1 mucin-type O-glycans. Methods: We studied plasma samples from 55 patients with various primary defects in N- and/or O-glycosylation, 21 patients with secondary N-glycosylation defects, and 6 patients with possible glycosylation abnormalities. Furthermore, we analyzed 500 plasma samples that were sent to our laboratory for selective screening for inborn errors of metabolism. Results: Plasma samples from patients with congenital disorders of glycosylation (CDG) types –IIe and –IIf showed a hypoglycosylated apoC-III isoform profile, as did plasma samples from 75% of the patients with an unspecified CDG type II. Hyposialylated O-glycan profiles were also seen in plasma from 2 patients with hemolytic-uremic syndrome. In the 500 plasma samples from the selective screening, 3 patients were identified with a possible isolated defect in the biosynthesis of core 1 mucin-type O-glycans. Conclusions: To our knowledge this is the first study in which use of a plasma marker protein has identified patients in whom only O-glycan biosynthesis might be affected. The primary defect(s) remain as yet unknown. Plasma apoC-III IEF is complementary to transferrin isofocusing. In conjunction both tests identify biosynthesis defects in N-glycan and mucin-type core 1 O-glycan biosynthesis. The apoC-III IEF assay is likely to help metabolic laboratories to identify and unravel further subtypes of inborn errors of glycan biosynthesis.

APA, Harvard, Vancouver, ISO, and other styles

Eckardt, Veit, Christian Weber, and Philipp von Hundelshausen. "Glycans and Glycan-Binding Proteins in Atherosclerosis." Thrombosis and Haemostasis 119, no. 08 (July 2, 2019): 1265–73. http://dx.doi.org/10.1055/s-0039-1692720.

Full text

Abstract:

AbstractComplex glycans are readily accessible on the endothelium and on cell and plasma components. They interact with glycan-binding proteins which translate their structure into function. Advanced analytical tools are available to investigate their structure and functional interactions. Modifications to glycan structures which alter their capacity to bind proteins are particularly relevant in atherosclerosis. We summarize the regulatory role of glycans and their binding partners in the development of the disease. Given their complexity, accessibility, and important functional role, glycans and glycan-binding proteins represent promising diagnostic tools and therapeutic targets.

APA, Harvard, Vancouver, ISO, and other styles

Chen, Jie, Xueli Li, Andrew Edmondson, Gail Ditewig Meyers, Kosuke Izumi, Amanda M. Ackermann, Eva Morava, Can Ficicioglu, Michael J. Bennett, and Miao He. "Increased Clinical Sensitivity and Specificity of Plasma Protein N-Glycan Profiling for Diagnosing Congenital Disorders of Glycosylation by Use of Flow Injection–Electrospray Ionization–Quadrupole Time-of-Flight Mass Spectrometry." Clinical Chemistry 65, no. 5 (May 1, 2019): 653–63. http://dx.doi.org/10.1373/clinchem.2018.296780.

Full text

Abstract:

Abstract BACKGROUND Congenital disorders of glycosylation (CDG) represent 1 of the largest groups of metabolic disorders with >130 subtypes identified to date. The majority of CDG subtypes are disorders of N-linked glycosylation, in which carbohydrate residues, namely, N-glycans, are posttranslationally linked to asparagine molecules in peptides. To improve the diagnostic capability for CDG, we developed and validated a plasma N-glycan assay using flow injection–electrospray ionization–quadrupole time-of-flight mass spectrometry. METHODS After PNGase F digestion of plasma glycoproteins, N-glycans were linked to a quinolone using a transient amine group at the reducing end, isolated by a hydrophilic interaction chromatography column, and then identified by accurate mass and quantified using a stable isotope-labeled glycopeptide as the internal standard. RESULTS This assay differed from other N-glycan profiling methods because it was free of any contamination from circulating free glycans and was semiquantitative. The low end of the detection range tested was at 63 nmol/L for disialo-biantennary N-glycan. The majority of N-glycans in normal plasma had <1% abundance. Abnormal N-glycan profiles from 19 patients with known diagnoses of 11 different CDG subtypes were generated, some of which had previously been reported to have normal N-linked protein glycosylation by carbohydrate-deficient transferrin analysis. CONCLUSIONS The clinical specificity and sensitivity of N-glycan analysis was much improved with this method. Additional CDGs can be diagnosed that would be missed by carbohydrate-deficient transferrin analysis. The assay provides novel biomarkers with diagnostic and potentially therapeutic significance.

APA, Harvard, Vancouver, ISO, and other styles

Ashwood, Heather E., Christopher Ashwood, Anna P. Schmidt, Rebekah L. Gundry, Karin M. Hoffmeister, and Waseem Q. Anani. "Characterization and statistical modeling of glycosylation changes in sickle cell disease." Blood Advances 5, no. 5 (March 5, 2021): 1463–73. http://dx.doi.org/10.1182/bloodadvances.2020003376.

Full text

Abstract:

AbstractSickle cell disease is an inherited genetic disorder that causes anemia, pain crises, organ infarction, and infections in 13 million people worldwide. Previous studies have revealed changes in sialic acid levels associated with red blood cell sickling and showed that stressed red blood cells bare surface-exposed clustered terminal mannose structures mediating hemolysis, but detailed glycan structures and anti-glycan antibodies in sickle cell disease remain understudied. Here, we compiled results obtained through lectin arrays, glycan arrays, and mass spectrometry to interrogate red blood cell glycoproteins and glycan-binding proteins found in the plasma of healthy individuals and patients with sickle cell disease and sickle cell trait. Lectin arrays and mass spectrometry revealed an increase in α2,6 sialylation and a decrease in α2,3 sialylation and blood group antigens displayed on red blood cells. Increased binding of proteins to immunogenic asialo and sialyl core 1, Lewis A, and Lewis Y structures was observed in plasma from patients with sickle cell disease, suggesting a heightened anti-glycan immune response. Data modeling affirmed glycan expression and plasma protein binding changes in sickle cell disease but additionally revealed further changes in ABO blood group expression. Our data provide detailed insights into glycan changes associated with sickle cell disease and refer glycans as potential therapeutic targets.

APA, Harvard, Vancouver, ISO, and other styles

Kratz, Ewa M., Anna Kałuża, Mariusz Zimmer, and Mirosława Ferens-Sieczkowska. "The Analysis of Sialylation,N-Glycan Branching, and Expression ofO-Glycans in Seminal Plasma of Infertile Men." Disease Markers 2015 (2015): 1–7. http://dx.doi.org/10.1155/2015/941871.

Full text

Abstract:

Carbohydrates are known to mediate some events involved in successful fertilization. Although some studies on the glycosylation of seminal plasma proteins are available, the total glycan profile was rarely analyzed as a feature influencing fertilization potential. In this work we aimed to compare some glycosylation traits in seminal plasma glycoproteins of fertile and infertile men. The following findings emerge from our studies: (1) in human seminal plasma the presence and alterations ofO-linked glycans were observed; (2) the expression of SNA-reactive sialic acid significantly differs between asthenozoospermia and both normozoospermic (fertile and infertile) groups; (3) the expression of PHA-L-reactive highly branchedN-glycans was significantly lower in oligozoospermic patients than in both normozoospermic groups. Indication of the appropriate lectins that would enable the possibly precise determination of the glycan profile seems to be a good supplement to mass spectrum analysis. Extension of the lectin panel is useful for the further research.

APA, Harvard, Vancouver, ISO, and other styles

Canis, Kevin, Thomas A. J. McKinnon, Agata Nowak, Stuart M. Haslam, Maria Panico, Howard R. Morris, Mike A. Laffan, and Anne Dell. "Mapping the N-glycome of human von Willebrand factor." Biochemical Journal 447, no. 2 (September 26, 2012): 217–28. http://dx.doi.org/10.1042/bj20120810.

Full text

Abstract:

vWF (von Willebrand factor) is a key component for maintenance of normal haemostasis, acting as the carrier protein of the coagulant Factor VIII and mediating platelet adhesion at sites of vascular injury. There is ample evidence that vWF glycan moieties are crucial determinants of its expression and function. Of particular clinical interest, ABH antigens influence vWF plasma levels according to the blood group of individuals, although the molecular mechanism underlying this phenomenon remains incompletely understood. The present paper reports analyses of the human plasma vWF N-glycan population using advanced MS. Glycomics analyses revealed approximately 100 distinct N-glycan compositions and identified a variety of structural features, including lactosaminic extensions, ABH antigens and sulfated antennae, as well as bisecting and terminal GlcNAc residues. We estimate that some 300 N-glycan structures are carried by human vWF. Glycoproteomics analyses mapped ten of the consensus sites known to carry N-glycans. Glycan populations were found to be distinct, although many structural features were shared across all sites. Notably, the H antigen is not restricted to particular N-glycosylation sites. Also, the Asn2635 site, previously designated as unoccupied, was found to be highly glycosylated. The delineation of such varied glycan populations in conjunction with current models explaining vWF activity will facilitate research aimed at providing a better understanding of the influence of glycosylation on vWF function.

APA, Harvard, Vancouver, ISO, and other styles

Chatterton, B. D., J. Mullington, H. Yang, M. Haack, R. Cummings, and S. D. Lehoux. "0058 Effects of Acute Total Sleep Deprivation on Human Plasma N-glycans." Sleep 43, Supplement_1 (April 2020): A23. http://dx.doi.org/10.1093/sleep/zsaa056.056.

Full text

Abstract:

Abstract Introduction There is a need for a novel biomarker that can be used to measure sleep sufficiency as it pertains to fitness for duty. As glycans (polysaccharides) are known to be involved in modifying protein effectiveness, we are exploring these as biomarkers that may be sensitive to differences between sleep deprivation and normal healthy adult sleep duration. We have measured one major class of glycans, called N-glycans, which are covalently linked to asparagine residues of polypeptide chains of membrane-bound and secreted proteins. We compared the plasma N-glycan profiles of participants before and after they participated in a total sleep deprivation protocol. Methods 10 healthy participants (6 male, 4 female) aged 30–44 went through 88 hours of total sleep deprivation. Hourly blood draws were taken via forearm catheter throughout the protocol. N-glycan analysis was performed using plasma samples collected at 17:35 prior to the first night of sleep deprivation and at 17:35 following 82.5 hours of continuous wakefulness. N-glycans were first cleaved from peptides and isolated from plasma, and profiles were then measured using Matrix-Assisted Laser Desorption/Ionization-Time of Flight (MALDI-TOF) mass spectrometry. Results 66 N-glycans were observed in our profiles. Of these, the relative abundance of 17 N-glycans were significantly different following sleep deprivation (paired t-test, 13 with p<0.05, 4 with p<0.01). In each case, the relative abundance was lower in the sleep deprivation time point. We found two structures, Hex6HexNAc5NeuAc3 and Hex7HexNAc6NeuAc2, which were also significant in one of our previous chronic sleep restriction protocols. Conclusion While we observed that many N-glycans decreased in relative abundance, it is unclear whether these changes represent a shift in glycan synthesis or result from decreased expression of the proteins they are bound to. Our next steps involve exploring the functions of the proteins associated with Hex6HexNAc5NeuAc3 and Hex7HexNAc6NeuAc2, and measuring their expression levels. Support NIH/HL75501; NIH/National Center for Research Resources UL1-RR02758 and M01-RR01032 to the Harvard Clinical and Translational Science Center.

APA, Harvard, Vancouver, ISO, and other styles

Simunovic, Jelena, Marija Vilaj, Irena Trbojevic-Akmacic, Ana Momcilovic, Frano Vuckovic, Ivan Gudelj, Julija Juric, Natali Nakic, Gordan Lauc, and Marija Pezer. "Comprehensive N-glycosylation analysis of immunoglobulin G from dried blood spots." Glycobiology 29, no. 12 (May 30, 2019): 817–21. http://dx.doi.org/10.1093/glycob/cwz061.

Full text

Abstract:

Abstract Immunoglobulin G (IgG) glycans are emerging as a new putative biomarker for biological age and different diseases, requiring a robust workflow for IgG glycome analysis, ideally beginning with a simple and undemanding sampling procedure. Here, we report the first comprehensive study on total N-glycans of IgG isolated from dried blood spots (DBSs), which was performed in a high-throughput mode. We compared the IgG N-glycan profiles originating from DBS with those originating from plasma, compared different media for DBS collection, evaluated analytical variation and assessed IgG N-glycan profile stability for different storage conditions. In conclusion, we show that DBSs are a good and stable source material for a robust IgG N-glycan analysis by ultra-performance liquid chromatography, suitable for blood sampling in conditions where no trained personnel and necessary laboratory equipment are available.

APA, Harvard, Vancouver, ISO, and other styles

Nakahara, Taku, Diane McCarthy, Yoshiaki Miura, and Hidehisa Asada. "High-throughput glycomics for discovery of cancer biomarkers." Journal of Clinical Oncology 30, no. 30_suppl (October 20, 2012): 9. http://dx.doi.org/10.1200/jco.2012.30.30_suppl.9.

Full text

Abstract:

9 Background: While the importance of glycosylation in many cancers is well established, the use of glycomics in biomarker research has lagged behind genomics and proteomics. This is due, in part, to the lack of practical platforms capable of analyzing clinically relevant sample numbers. To address these challenges, we have developed a novel glycomics technology (the GlycanMap platform) that combines a high-throughput assay with custom bioinformatics and rapidly provides both biomarker candidates and information on the underlying biology. Methods: N-glycans were enzymatically released from their parent glycoproteins and captured on chemoselective beads. After washing to remove non-glycan components, purified glycans were derivatized to stabilize labile sialic acids and released from the beads. The steps described above were automated on a 96-well format robotics system to maximize throughput and reduce variability and can be performed in less than 24 hours. Released glycans were analyzed by MALDI-TOF MS using internal standards to facilitate quantitation. In addition to comparing individual glycans between groups, glycan changes were also analyzed with respect to known glycan biosynthetic pathways. Results: The automated assay was compatible with multiple biological sample types, including serum/plasma, tissue, and cell lysates. Human serum was used to assess assay performance and yielded 50-60 glycans with CVs of 10-15% and good linearity. The lower limit of detection was approximately 100 nM. The assay was applied to drug-treated colon cancer cells (HCT116) and revealed significant (> 2-fold) changes in 17 glycans. Projection of these glycan changes on the known N-glycan pathway showed that the most significant changes occurred in the medial-Golgi. Conclusions: We have developed and optimized a high-throughput glycomics platform to facilitate large-scale biomarker studies and assured its practical performance in terms of sensitivity, repeatability, and linearity. Application of this assay to drug-treated colon cancer cells demonstrated that projection of individual glycan changes against known glycan pathways provided additional information about biological mechanism and relevance.

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Plasma glycan"

Pathak, Shantanu Chaturvedi. "Characterization of plasma-polymerized polyethylene glycol-like films." Diss., Atlanta, Ga. : Georgia Institute of Technology, 2008. http://hdl.handle.net/1853/31789.

Full text

Abstract:

Thesis (Ph.D)--Chemical Engineering, Georgia Institute of Technology, 2009.
Committee Chair: Dr. Dennis W. Hess; Committee Member: Dr. Clifford L. Henderson; Committee Member: Dr. J. Carson Meredith; Committee Member: Dr. L. Andrew Lyon; Committee Member: Dr. Mark R. Prausnitz. Part of the SMARTech Electronic Thesis and Dissertation Collection.

APA, Harvard, Vancouver, ISO, and other styles

Nisol, Bernard. "Atmospheric pressure plasma synthesis of biocompatible poly(ethylene glycol)-like coatings." Doctoral thesis, Universite Libre de Bruxelles, 2011. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/209928.

Full text

Abstract:

The role of a protein-repelling coating is to limit the interaction between a device and its physiological environment. Plasma-polymerized-PEG (pp-PEG) surfaces are of great interest since they are known to avoid protein adsorption. and cell attachment. However, in all the studies previously published in the literature, the PEG coatings have been prepared using low pressure processes.

In this thesis, we synthesize biocompatible pp-PEG coatings using atmospheric pressure plasma. Two original methods are developed to obtain these pp-PEG films. 1. Atmospheric pressure plasma liquid deposition (APPLD) consists in the injection of the precursor, tetra(ethylene glycol)dimethylether (tetraglyme), by means of a liquid spray, directly in the post-discharge of an atmospheric argon plasma torch. 2. In atmospheric pressure plasma-enhanced chemical vapor deposition (APPECVD), tetraglyme vapors are brought in the post-discharge trough a heating sprinkler. The chemical composition, as well as the non-fouling properties of the APPLD and APPECVD films, are compared to those of PEG coatings synthesized by conventional low pressure plasma processes.

In the first part of the study, the effect of the power on the chemical composition of the films has been investigated by infrared reflection absorption spectroscopy (IRRAS), X-ray photoelectron spectroscopy (XPS) and secondary ions mass spectroscopy (SIMS).

The surface analysis reveals that for the APPECVD samples, the fragmentation of the precursor increases as the power of the treatment is increased. In other terms, the lower the plasma power is, the higher the “PEG character” of the resulting films is. Indeed, the C-O component (286.5 eV) of the XPS C 1s peak is decreasing while the hydrocarbon component (285 eV) is increasing as the power of the plasma is increased. The same conclusion can be drawn from the signature ToF-SIMS peaks (m/z = 45 (CH3&61485;O&61485;CH2+ and +CH2CH2&61485;OH), 59 (CH3&61485;O&61485;CH2&61485;CH2+), 103 (CH3&61485;(O&61485;CH2&61485;CH2)2+)) that are decreasing in the case of high power treatments. Accordingly, IRRAS measurements show that the C-O stretching band is decreasing for high power plasma deposition. This is in agreement with the observations made from the analysis of the LP PECVD coatings and from the literature.

The films deposited by the APPLD process do not show the same behavior. Indeed, whatever the power injected into the discharge is, we are able to achieve films with a relatively high PEG character (&61566;83 %).

The second part of this study is dedicated to the evaluation of the non-fouling properties of the coatings by exposing them to proteins (bovine serum albumin and human fibrinogen) and cells (mouse fibroblasts (L929 and MEF)) and controlling the adsorption with XPS (proteins) and SEM (cells).

For the APPECVD samples, a low plasma power (30 W) leads to an important reduction of protein adsorption and cell adhesion (over 85%). However, higher-powered treatments tend to reduce the non-fouling ability of the surfaces (around 50% of reduction for a 80 W deposition).

The same order of magnitude (over 90% reduction of the adsorption) is obtained for the APPLD surfaces, whatever is the power of the treatment.

Those results show an important difference between the two processes in terms of power of the plasma treatment, and a strong relationship between the surface chemistry and the adsorption behavior: the more the PEG character is preserved, the more protein-repellent and cell-repellent is the surface. / Le rôle d’une couche empêchant l’adsorption de protéines est de limiter les interactions entre un implant et le milieu physiologique auquel il est exposé. Les films de poly(éthylène glycol) polymérisés par plasma (pp-PEG) sont d’intérêt majeur car ils sont connus pour empêcher l’adsorption de protéines ainsi que l’attachement cellulaire. Cependant, dans toutes les études publiées précédemment, les couches de type PEG ont été réalisées sous vide.

Dans cette thèse de doctorat, nous synthétisons des couches de type pp-PEG biocompatibles par plasmas à pression atmosphérique. A cette fin, deux méthodes originales ont été développées. 1. La première méthode consiste en l’injection du précurseur, le tetra(éthylène glycol) diméthyl éther (tetraglyme), en phase liquide, en nébulisant ce dernier au moyen d’un spray, directement dans la post-décharge d’une torche à plasma atmosphérique fonctionnant à l’argon. En anglais, nous appelons ce procédé « Atmospheric pressure plasma liquid deposition (APPLD) ». 2. Dans la deuxième méthode, appelée en anglais « Atmospheric pressure plasma-enhanced chemical vapor deposition (APPECVD)», le tetraglyme est amené en phase vapeur dans la post-décharge, au moyen d’un diffuseur chauffant. La composition chimique des dépôts de type APPLD et APPECVD, ainsi que leurs propriétés d’anti-adsorption sont évaluées, et comparées aux dépôts pp-PEG obtenus par les méthodes à basse pression conventionnelles.

Dans la première partie de cette étude, nous nous focalisons sur la composition chimique des films déposés, et plus particulièrement sur l’influence de la puissance injectée dans le plasma sur cette composition chimique. A cette fin, nous avons fait appel à des techniques d’analyse telles que la spectroscopie de réflexion-absorption infrarouge (IRRAS), la spectroscopie des photoélectrons X (XPS) et la spectrométrie de masse des ions secondaires (SIMS).

Il en ressort que les films de type APPECVD perdent progressivement leur « caractère PEG » à mesure que la puissance de la décharge plasma est élevée. Cela serait dû à une plus grande fragmentation du précurseur dans la post-décharge d’un plasma plus énergétique. Cette tendance est cohérente avec ce que nous avons observé pour les dépôts à basse pression ainsi que dans la littérature.

Dans le cas des films de type APPLD, un tel comportement n’a pas été mis en évidence :quelle que soit la puissance dissipée dans le plasma, les films présentent un « caractère PEG » relativement élevé.

La deuxième partie de cette thèse est dédiée à l’évaluation des propriétés d’anti-adsorption des films synthétisés, en les exposant à des protéines (albumine de sérum bovin et fibrinogène humain) et des cellules (fibroblastes de souris, L929 et MEF). L’adsorption de protéines est contrôlée par XPS tandis que l’attachement cellulaire est contrôlé par imagerie SEM.

Pour les échantillons de type APPECVD, un dépôt à faible puissance (30 W) mène à une importante réduction de l’adsorption de protéines et de cellules (> 85%) tandis qu’à de plus hautes puissances (80 W), l’anti-adsorption est sensiblement diminuée (50% de réduction). Dans le cas des dépôts de type APPLD, quelle que soit la puissance du plasma, une forte diminution de l’adsorption de protéines et de cellules est observée (> 90 %).

Ces résultats montrent une différence majeure entre les deux procédés quant à l’influence de la puissance du plasma ainsi qu’une forte relation entre la composition chimique de la surface synthétisée et son pouvoir d’anti-adsorption :plus le « caractère PEG » du dépôt est conservé, plus la surface empêchera l’interaction avec les protéines et les cellules.

Doctorat en Sciences
info:eu-repo/semantics/nonPublished

APA, Harvard, Vancouver, ISO, and other styles

Devlin, John Patrick. "Spoonful of sugar helps the medicine go down : biomanufacture in glycoengineered Pichia pastoris of the potentially therapeutic recombinant glycoprotein factor H." Thesis, University of Edinburgh, 2018. http://hdl.handle.net/1842/33084.

Full text

Abstract:

Glycoengineering is a technology that could improve protein therapeutics. While protein glycosylation in general enhances solubility and stability, and reduces aggregation, immunogenicity and proteolysis, specific kinds of glycosylation may also be critical. For example, capping of glycans with N-acetylneuraminic acid (Neu5Ac) maximises circulatory half-life in humans. Moreover, some glycans directly participate in molecular recognition and other aspects of glycoprotein function. Glycoproteins produced by non-human mammalian cells carry glycans capped by N-glycolyl-neuraminic acid rather than Neu5Ac. Yet production in human cell lines is costly and slow, requires specialist facilities, produces low yields and is subject to additional regulations. Hence there is a case for glycoengineering alternative expression systems capable of rapid, low-cost, high-yield glycoprotein production. This report focuses on the glycoengineering of Pichia pastoris, a yeast, to produce recombinant human glycoprotein factor H (FH) bearing human-like glycans. FH is a potent down-regulator of the complement system. Mutations and SNPs in FH result in autoimmune diseases such as atypical haemolytic ureamic syndrome and age-related macular degeneration (AMD). Recombinant FH is an enticing therapeutic candidate for treating AMD, but high doses are required since FH is abundant (200-300 mg l-1) in normal human serum. Human FH (155 kDa), with eight sites of N-linked glycosylation and 40 disulphides, is a challenging target for recombinant production. Yet FH was previously expressed to 10s of milligrams in P. pastoris. In this study, methods were established to confirm that human plasma-derived (h)FH carries predominantly N-linked diantennary disialylated complex-type glycans, with monosialylated diantennary structures and triantennary structures in fucosylated and non-fucosylated forms, contributing to glycan heterogeneity. Functional comparison of native hFH, enzymatically desialylated (DeSia-) hFH and deglycosylated recombinant P. pastoris-produced (DeGly-r)FH showed that DeSia-hFH had the lowest affinity for complement protein C3b, its key target. Moreover, DeSia-hFH binds C3d, an opsonic C3b-breakdown product, whereas native hFH does not. DeSia-hFH had an improved ability to accelerate decay of the C3 convertase (an enzyme that cleaves C3 to C3b) compared to native hFH, but neither was as good as DeGly-rFH in this respect. In contrast, DeGly-rFH had reduced cofactor activity (for factor I-mediated degradation of C3b) compared to native hFH whereas DeSiahFH did not have reduced cofactor activity. These data suggest that sialylation of FH glycans may play a role in stabilising a conformation of circulating FH that is not fully effective, consistent with specificity for self-surfaces and resistance to bacterial hijack. Aiming eventually to produce human-like glycosylated FH in glycoengineered P. pastoris, the SuperMan 5 strain served as a starting point. While conventional strains of P. pastoris put hypermannosylated N-linked glycans on proteins, glycans on SuperMan 5-produced FH were shown to contain just five mannose (Man) residues. In further glycoengineering, and following unsuccessful efforts to use inABLE technology for this purpose, commercially available (GlycoSwitch) vectors were used to introduce genes encoding the glycosyltransferase enzymes N-acetylglucosamine (GlcNAc) transferase I (GnTI) and galactose (Gal) transferase. These catalysed the formation of a hybrid-type glycan containing an N-acetyllactosamine (Gal-β(1,4)-GlcNAc (LacNAc)) antennae on a five-mannose glycan. Then two more GlycoSwitch plasmids, containing genes encoding α-Mannosidase II (ManII) and GnTII, were introduced into P. pastoris to catalyse the formation of a second LacNAc antennae. MALDI-TOF analysis found the glycosylation of this strain to be heterogeneous, containing the humanised diantennary digalactosyl glycan as well as other endogenous yeast glycans. This strain was designated SuperGal. Large-scale expression of rFH with terminally galactosylated complex-type glycans (Gal-rFH) in SuperGal yielded 100s of milligrams of purified Gal-rFH. Yeast-type glycans were enzymatically removed from rFH and the remaining complex-type humanised glycans were sialylated with a recombinant bacterial α(2,6)-sialyltransferase from Photobacterium sp. expressed in E.coli. Purified sialylated (Sia-) and non-sialylated (Gal-) rFH expressed in SuperGal were functionally characterised in vitro using SPR-based assays. In C3b-binding assays Sia-rFH had lower affinity compared to Gal-rFH. Both bound with lower affinity than DeGly-rFH. A similar pattern of binding affinity was seen for C3d. In C3 convertase decay-acceleration assays, all rFH glycoforms performed equally well and had greater activity than hFH. Conversely, Sia-and Gal-rFH were shown to perform equally as well as hFH in CA assays, while all three versions outperformed DeGly-rFH. However, in vivo complement activity assay carried out in a FH-knockout mouse model showed that humanisation of the glycosylation of rFH did not significantly improve activity compared to DeGly-rFH. In addition, analysis of the circulatory half-life of rFH showed that humanisation did not improve half-life. Further engineering steps will be required to increase the complex-type glycan site occupancy on rFH with a view to improving circulatory half-life and efficacy. However, this study represents a significant step forward in developing a therapeutically useful source of rFH.

APA, Harvard, Vancouver, ISO, and other styles

Bacharouche, Jalal. "De nouvelles surfaces à reconnaissance moléculaire activée par élongation." Thesis, Mulhouse, 2012. http://www.theses.fr/2012MULH4471.

Full text

Abstract:

Le procédé par lequel des forces sont transformées en signaux chimiques joue un rôle fondamental dans de nombreux processus biologiques. Ce travail de thèse a permis de mettre au point de nouvelles surfaces fonctionnelles synthétiques permettant de mimer ce comportement. Il s’agit plus précisément de contrôler l’adsorption d’objets biologiques tels que des protéines ou des cellules sur un support élastique modifié par plasma et présentant des récepteurs spécifiques. Ces récepteurs sont masqués par de longues chaînes de poly(éthylèneglycol) (PEG) qui sont également greffées sur la surface. L'étirement de celles-ci permet d'exhiber les sites d’adsorption ou les sites d'adhésion et de rendre ainsi la surface adhérente. Notre méthode est basée sur la polymérisation plasma de l’anhydride maléique. Cette fonctionnalisation permet de greffer à la surface de films silicones des fonctions carboxylique qui servent de points d’ancrage aux chaînes de PEG. Sur le même principe, la biotine ou les peptides d’adhésion (RGD) sont greffés dans un deuxième temps sur ce substrat. Nous montrons, qu’à l’état non étiré, ces ligands ne sont pas accessibles pour leurs récepteurs. Par contre, à l’état étiré, la surface devient spécifiquement adsorbante pour la streptavidine, l’anti-biotine et adhérente pour les cellules. Ces phénomènes sont parfaitement réversibles
The process by which forces are converted into chemical signals play a fundamental role in many biological processes. This thesis has to develop new functional synthetic surfaces to mimic this behavior. It is more precisely to control the adsorption of biological objects such as proteins or cells on an elastic support modified by plasma and presenting specific receptors. These receptors are masked by long chains of poly (ethylene glycol) (PEG) which are also grafted onto the surface. Stretching allows them to exhibit adsorption sites or adhesion sites and thus make the surface adhesive. Our method is based on the plasma polymerization of maleic anhydride. This functionalization can be grafted to the surface of silicone films carboxylic functions which serve as anchors points for the PEG chains. On the same principle, biotin or adhesion peptides (RGD) have been grafted in a second time on this substrate. We show that the non-stretched state, these ligands are not accessible to their receptors. On the other side, in the stretched state, the surface becomes specifically adsorbent to streptavidin, anti-biotin and also adherent for cells. These phenomena are perfectly reversible

APA, Harvard, Vancouver, ISO, and other styles

PINNAMANENI, POORNIMA. "BORONIC ACID MACROLIGANDS FOR GLYCOMICS APPLICATIONS." Cleveland State University / OhioLINK, 2012. http://rave.ohiolink.edu/etdc/view?acc_num=csu1347558235.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Letchford, Kevin John. "Development of methoxy poly(ethylene glycol)-block-poly(caprolactone) amphiphilic diblock copolymer nanoparticulate formulations for the delivery of paclitaxel." Thesis, University of British Columbia, 2008. http://hdl.handle.net/2429/2487.

Full text

Abstract:

The goal of this project was to develop a non-toxic amphiphilic diblock copolymer nanoparticulate drug delivery system that will solubilize paclitaxel (PTX) and retain the drug in plasma. Methoxy poly(ethylene glycol)-block-poly(ε-caprolactone) (MePEG-b-PCL) diblock copolymers loaded with PTX were characterized and their physicochemical properties were correlated with their performance as nanoparticulate drug delivery systems. A series of MePEG-b-PCL was synthesized with PCL blocks ranging from 2-104 repeat units and MePEG blocks of 17, 44 or 114 repeat units. All copolymers were water soluble and formed micelles except MePEG₁₁₄-b-PCL₁₀₄, which was water insoluble and formed nanospheres. Investigation of the effects of block length on the physicochemical properties of the nanoparticles was used to select appropriate copolymers for development as PTX nanoparticles. The critical micelle concentration, pyrene partition coefficient and diameter of nanoparticles were found to be dependent on the PCL block length. Copolymers based on a MePEG molecular weight of 750 g/mol were found to have temperature dependent phase behavior. Relationships between the concentration of micellized drug and the compatibility between the drug and core-forming block, as determined by the Flory-Huggins interaction parameter, and PCL block length were developed. Increases in the compatibility between PCL and the drug, as well as longer PCL block lengths resulted in increased drug solubilization. The physicochemical properties and drug delivery performance characteristics of MePEG₁₁₄-b-PCL₁₉ micelles and MePEG₁₁₄-b-PCL₁₀₄ nanospheres were compared. Nanospheres were larger, had a more viscous core, solubilized more PTX and released it slower, compared to micelles. No difference was seen in the hemocompatibility of the nanoparticles as assessed by plasma coagulation time and erythrocyte hemolysis. Micellar PTX had an in vitro plasma distribution similar to free drug. The majority of micellar PTX associated with the lipoprotein deficient plasma fraction (LPDP). In contrast, nanospheres were capable of retaining more of the encapsulated drug with significantly less PTX partitioning into the LPDP fraction. In conclusion, although both micelles and nanospheres were capable of solubilizing PTX and were hemocompatible, PTX nanospheres may offer the advantage of prolonged blood circulation, based on the in vitro plasma distribution data, which showed that nanospheres retained PTX more effectively.

APA, Harvard, Vancouver, ISO, and other styles

Cavalini, Eliseu Antonio [UNESP]. "Filmes nanométricos obtidos a plasma da mistura ácido cítrico-etilenoglicol-metal complexador." Universidade Estadual Paulista (UNESP), 2016. http://hdl.handle.net/11449/147126.

Full text

Abstract:

Submitted by Eliseu Antonio Cavalini null (cavaliniea1356@ig.com.br) on 2017-01-08T01:45:41Z No. of bitstreams: 1 Tese Dout V Final.pdf: 2360887 bytes, checksum: 17f60dc9305936e9dd9ea3744d049148 (MD5)
Approved for entry into archive by Juliano Benedito Ferreira (julianoferreira@reitoria.unesp.br) on 2017-01-11T13:28:41Z (GMT) No. of bitstreams: 1 cavalini_ea_dr_guara.pdf: 2360887 bytes, checksum: 17f60dc9305936e9dd9ea3744d049148 (MD5)
Made available in DSpace on 2017-01-11T13:28:41Z (GMT). No. of bitstreams: 1 cavalini_ea_dr_guara.pdf: 2360887 bytes, checksum: 17f60dc9305936e9dd9ea3744d049148 (MD5) Previous issue date: 2016-12-09
Plasmas de gases e / ou vapores orgânicos produzem filmes finos ou pós apresentando características poliméricas, especialmente quando os plasmas são derivados de monômeros das famílias dos hidrocarbonetos alcoóis, siloxanos, silazanos, e outro. Neste trabalho, os filmes finos foram obtidos a partir da mistura de ácido cítrico-etilenoglicol-metal complexador depositado a plasma, com 13,56 MHz de radiofrequência na potência de 10 a 50 W e pressão fixada a 10 Pa. Os resultados da análise de espectroscopia de infravermelho FTIR mostrou que os grupos vibracionais dos filmes estavam preservados, mas com modificações em suas estruturas moleculares. Foram observados nos resultados obtidos por espectroscopia fotoelétrica de raios-X modificações na composição química da ligação oxigênio-carbono e oxigênio-hidrogênio com variação da potência de 10 a 50 W. A taxa de deposição dos filmes finos diminuiu de 0,10 a 0,08 nm/minuto com o aumento da potência de 10 a 50 W. As propriedades óticas das amostras como o índice de refração, coeficiente de absorção, gap ótico foram investigados por espectroscopia UV- visível. Destas análises foram possíveis obter valores n de 1,54 a 1,50 e energia do gap entre 4,75 e 4,85 eV. A técnica de ângulos de contato e foi utilizada para investigar a molhabilidade das amostras, que apresentaram caráter hidrofílico em todas as condições de deposição dos filmes. A técnica de EDS foi usada para investigar as composições químicas das amostras. Além disso, os filmes obtidos apresentaram valores de condutividade elétrica superior a 10-8 (Ωcm)-1 e constantes dielétricas entre 2,4 e 2,7.
Plasmas from gases and / or organic vapors produce thin films or powders presenting polymeric characteristics, especially when the plasmas are derived from monomers of the families of hydrocarbons, alcohols, siloxanes, silazanes, and others. In this work, thin films were obtained by citric acid / ethylene glycol / complex metal deposited by 13.56 MHz RF plasma at 10 and 50 W fixed pressure 10 Pa. FTIR spectroscopy showed that the main vibrational groups of the films were preserved, but with modifications in their molecular structures. It was observed by X –ray photoelectron spectroscopy chemical composition modifications in oxygen – carbon and oxygen – hydrogen bond while the deposition power changed from 10 to 50 W. The deposition rate of the samples decreased from 0.10 to 0.08 nm / minute while the RF power increases from 10 to 50 W. The samples optical properties as refractive index n, absorption coefficient, optical gap Eg were investigated by UV – Visible spectroscopy. From these analysis were possible to obtain values of n from 1.54 to 1.50 and Eg between 4.75 and 4.85 eV. Contact angle and surface energy measurements were used to investigate the wettability of composite Polymer films, for all depositions conditions the films presented hydrophilic character. EDS was used investigate components of the samples. Moreover, the film showed electrical conductivity values greater than 10-8(Ωcm)-1 and dielectric constant between 2.2 and 2.7.

APA, Harvard, Vancouver, ISO, and other styles

Sobral, Julia Kuklinsky. "A comunidade bacteriana endofítica e epifítica de soja (Glycine max) e estudo da interação endófitos-planta." Universidade de São Paulo, 2004. http://www.teses.usp.br/teses/disponiveis/11/11137/tde-24052004-154815/.

Full text

Abstract:

Bactérias endofíticas e epifíticas podem conferir ao seu hospedeiro características como maior resistência a condições de estresse, alterações nas condições fisiológicas, fixação de nitrogênio atmosférico, suprimento de nutrientes, produção de reguladores de crescimento vegetal, entre outros. Desta forma, o presente trabalho teve por objetivos estudar a composição da comunidade bacteriana associada à soja e avaliar diferentes mecanismos de interação bactéria-planta hospedeira. Para isso, bactérias endofíticas e epifíticas de folhas, caules e raízes de duas cultivares de soja, crescidas em solo com e sem aplicação pré-plantio do herbicida glifosato, foram amostradas em três estádios de desenvolvimento do hospedeiro, durante as safras de 2000/01 e 2001/02. Foram observadas diferenças significativas na diversidade e densidade bacterianas em relação às fases de crescimento da soja e tecidos da planta. Os principais grupos foram identificados como pertencentes aos gêneros Pseudomonas, Burkholderia, Ralstonia, Enterobacter, Pantoea, Acinetobacter, Agrobacterium e Methylobacterium. Além da avaliação de populações cultiváveis, análise por DGGE revelou que a comunidade bacteriana endofítica de raiz de soja pode ser influenciada pelo tratamento do solo com o herbicida glifosato. O potencial destas bactérias para a promoção de crescimento vegetal por bactérias associadas à soja foi avaliado, sendo possível observar que populações endofíticas e epifíticas de soja apresentam características relacionadas à promoção de crescimento vegetal e que fatores como cultivar e estádio fenológico do hospedeiro podem influenciar as freqüências destas populações. A análise da variabilidade genética destas populações bacterianas revelou que diferentes fatores ambientais também podem influenciar a diversidade de grupos bacterianos. Além disso, populações endofíticas com capacidade de crescer na presença do herbicida glifosato foram caracterizadas e identificadas como pertencentes às espécies Burkholderia gladioli e Pseudomonas oryzihabitans, enquanto que Methylobacterium spp. colonizam ativamente a superfície e os tecidos internos de soja após inoculação via semente. Os resultados obtidos podem oferecer uma contribuição para a melhor compreensão da interação microrganismossoja e, conseqüentemente, de sua aplicação na cultura deste vegetal.
Endophytic and epiphytic bacteria may increase the fitness of the plant host by increasing resistance to stress conditions, alterations in the physiologic conditions, fixation of atmospheric nitrogen, nutrient supplying and plant growth regulators production. The aims of the present work were to study the composition of soybean-associated bacterial community and to evaluate different mechanisms for bacteria-host plant interaction. For that, endophytic and epiphytic bacteria from leaves, stems and roots of two soybean cultivars, planted in soil with and without pre-planting application of the glyphosate herbicide, they were colleted in three development stages of the host, during two crops. Significant differences were observed in the bacterial diversity and population density in relation to the soybean growth stages and plant tissues. The principal groups were identified as belonging to the genera Pseudomonas, Burkholderia, Ralstonia, Enterobacter, Pantoea, Acinetobacter, Agrobacterium and Methylobacterium. Besides the evaluation of cultivable populations, analyses by DGGE revealed that the endophytic bacterial community from soybean roots may be influenced by the treatment of the soil with the glyphosate herbicide. Other analyzed aspect was the potential for plant growth promotion by soybean-associated bacteria; revealing that soybean's endophytic and epiphytic populations presented characteristics related to the plant growth promotion; factors such as cultivar and developmental stage of the host may influence the frequency of these populations. Environmental factors may affect the genetic variability of these bacterial populations. Besides, endophytic populations able to growth in medium containing glyphosate were characterized and identified as belonging to Burkholderia gladioli and Pseudomonas oryzihabitans species. Methylobacterium spp. were reintroduced in soybean seeds and superficial and endophytic colonization were evaluated by scanning electronic microscopy. The obtained results could offer a contribution for a better understanding of the interaction microorganism-soybean and, consequently, their possible use to improve soybean productivity.

APA, Harvard, Vancouver, ISO, and other styles

Balasubramanian, Shankar Ganesh Sokkalinga Simonian Aleksandr L. "Development of smart functional surfaces for biosensor applications." Auburn, Ala, 2008. http://repo.lib.auburn.edu/EtdRoot/2008/FALL/Materials_Engineering/Dissertation/Balasubramania_S%20G_2.pdf.

Full text

Abstract:

Thesis (Ph. D.)--Auburn University, 2008.
Abstract. Vita. The following patent resulted from the dissertation research: Davis, V., Simonian, A.L., Nepal, D., Balasubramanian, S, "Preparation of Precisely Controlled Thin Film Nanocomposites of Carbon Nanotubes and Biomaterials", U.S. Provisional Patent Application No. 61/000,938, filed on 30 October 2007. The following peer-reviewed publications resulted from the dissertation research: Dhriti Nepal, Shankar Balasubramanian, Aleksandr Simonian, and Virginia Davis, "Mechanically Strong Antibacterial Thin Film Based on Single-Walled Carbon Nanotubes Armored with Biopolymers", Nano Letters ASAP article, May 2008 (# equal contribution) -- Shankar Balasubramanian, Iryna B. Sorokulova, Vitaly J. Vodyanoy, and Aleksandr L. Simonian, "Lytic Phage as a Specific and Selective Probe For Detection of Staphylococcus Aureus: A Surface Plasmon Resonance Spectroscopic Study", Biosensors and Bioelectronics, 2007, 22, 948-955 -- Shankar Balasubramanian, Alexander Revzin, Aleksandr Simonian, "Electrochemical Desorption of Proteins from Gold Electrode Surface", Electroanalysis, 2006, 18, 1885-1892 (Invited article) -- Vishwaprakash Nanduri, Shankar Balasubramanian, Srinivas Sista, Vitaly J. Vodyanoy, and Aleksandr L. Simonian, "Highly Sensitive Phage-based Biosensor for the Detection of ß-galactosidase", Analytica Chimica Acta, 2007, 589, 166- 172 -- H. Luckarift, Shankar Balasubramanian, S. Paliwal, G. Johnson and A. Simonian, "Enzyme-Encapsulated Silica Monolayers For Rapid Functionalization of a Gold Surface", Colloids and Surfaces B: Biointerfaces, 2007, 58, 28-33 (Invited article) -- Dong Wei, Omar Oyarzabal, Tung-Shi Huang, Shankar Balasubramanian, Srinivas Sista, Aleksandr Simonian, "Development of Surface Plasmon Resonance Biosensor For The Identification of Campylobacter jejuni", Journal of Microbiological Methods, 2007, 69, 78-85. The following conferences presentations resulted from the dissertation research: Covalent Immobilization of Organophosphorus Hydrolase on Carbon Nanotubes for Biosensor Applications, accepted for oral presentation at 12th International Meeting on Chemical Sensors, Jul. 13-16, 2008, Columbus, OH -- Electrochemical characteristics of SWNT-biopolymer nanocomposites, accepted for 213th meeting of The Electrochemical Society, May 18-23, 2008, Phoenix, AR -- Mechanically Robust Antibacterial Thin Films Composed of Single-Walled Carbon Nanotubes and Biopolymers, 2008 AIChE Spring National Meeting, Apr. 6-10, New Orleans, LA -- Production and characterization of protein and DNA based single wall carbon nanocomposites by layer-by-layer assembly, MRS Fall Meeting, Nov. 26-30, 2007, Boston, MA -- Gold surface modified with enzyme-encapsulated silica monolayers for biosensor application, The 58th Southeast Regional Meeting of the American Chemical Society, Nov. 1-4, 2006, Augusta, GA -- Electrochemical modulation of biological interfaces, 209th meeting of The Electrochemical Society, May 7-12, 2006, Denver, CO -- SPR based biosensor using lytic phage as a specific and selective probe for staphylococcus aureus detection, 57th Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, Mar. 12-17, 2006, Orlando, FL -- Specific & selective detection of staphylococcus aureus by lytic phage using SPR biosensor, 57th Southeast / 61st Southwest Joint Regional Meeting of the American Chemical Society, Nov. 1-4, 2005, Memphis, TN -- Prevention of non-specific binding as a way to increase sensitivity of SPR-based sensors, 206th meeting of The Electrochemical Society, October 3-8, 2004, Honolulu, HI. Includes bibliographical references.

APA, Harvard, Vancouver, ISO, and other styles

Rechenmacher, Ciliana. "O papel das ureases de soja (Glycine max (L.)Merr.) no desenvolvimento da planta e na proteção contra nematoide causador de galha." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2016. http://hdl.handle.net/10183/163694.

Full text

Abstract:

Ureases são tradicionalmente conhecidas por catalisar a hidrólise da ureia em amônia e dióxido de carbono. Em soja, três isoformas de urease foram descritas: 1) urease ubíqua, codificada pelo gene Eu4; 2) urease embrião específica, codificada pelo gene Eu1; 3) urease SBU-III, codificada por Eu5. O nitrogênio (N) é o nutriente mais limitante para o crescimento e desenvolvimento da planta. Portanto, mecanismos eficientes para capturar o N nas suas diversas formas, e realocá-lo, são necessários para otimizar o uso do nutriente pela planta. O produto N da atividade da urease - a amônia é incorporada em compostos orgânicos, principalmente, pela atividade da glutamina sintetase. Assim, a urease está envolvida na remobilização do N, bem como na assimilação do N primário. Um estudo anterior foi realizado por nossa equipe com o objetivo de superexpressar o gene Eu4 em plantas de soja. Inesperadamente, as plantas transgênicas exibiram cosupressão do transgene Eu4 e de todos os genes endógenos que codificam as isoformas de urease. Foi verificada também, uma diminuição da atividade ureolítica. Visando determinar o papel das ureases no desenvolvimento da soja, foram comparadas plantas transgênicas co-suprimidas, plantas mutantes e seus respectivos controles. O desenvolvimento das plantas foi avaliado 7, 14, 21 e 30 dias após a semeadura. As plantas co-suprimidas apresentaram um atraso no desenvolvimento durante o primeiro mês após a germinação. Um desenvolvimento mais lento foi observado para o duplo mutante eu1- a/eu4- e o mutante simples eu3-a (este gene codifica uma proteína acessória inativa). A absorção de N nas plantas transgênicas foi significativamente menor do que a das plantas não transgênicas. Entre os mutantes, eu3-a apresentou o menor e eu1-a o maior conteúdo de N. Um número significativamente menor de sementes foi obtido para as plantas transgênicas. Em conjunto estes resultados indicam que o aconteúdo da urease ou da atividade ureolítica desempenham um papel importante no desenvolvimento da planta. A soja (Glycine max) é afetada por vários estresses bióticos e abióticos, que limitam a distribuição geográfica das culturas e levam a reduções significativas de crescimento e produtividade. No Brasil, as doenças causadas por nematoides são um dos estresses bióticos mais prejudiciais para a soja. As principais espécies encontradas no Brasil são Meloidogyne spp. (formadores de galhas), Heterodera glycines (cisto), Pratylenchus brachyurus (lesões radiculares) e Rotylenchulus reniformis (reniforme). Nematoides formadores de galhas e de cisto (nematóides sedentários), os patógenos mais prejudiciais à soja, são muito difíceis de controlar. Neste estudo, foi identificado um peptídeo derivado da urease de soja (nomeado Soyuretox), que exerce efeito tóxico contra fitonematoides formadores de galhas (M. javanica). Soyuretox foi expresso em raízes de plantas compostas plantas transgênicas estáveis de soja. Raízes de plantas compostas e plantas transgênicas estáveis superexpressando Soyuretox exibiram uma redução significativa (50% e 37.5%, respectivamente) no número médio de nematoides e ovos, quando comparado com raízes não transformadas, 45 dias após a inoculação. Este é o primeiro relato de resistência a nematóides causada por um peptideo derivado de uma urease. Soyuretox pode representar uma ferramenta útil bem como uma nova e eficiente alternativa para o controle de pragas e doenças em culturas economicamente importantes.
Ureases are traditionally known for catalyzing the hydrolysis of urea to ammonia and carbon dioxide. In soybean, three urease isoforms have been described: 1) ubiquitous urease, encoded by the Eu4 gene; 2) embryo-specific urease, encoded by Eu1gene; 3) SBU-III urease, encoded by Eu5. Nitrogen (N) is the most limiting nutrient for plant growth and development. Therefore efficient mechanisms both to take up N in its various forms, and to reallocate it, are necessary for optimal N use efficiency. The N product of urease activity- ammonia- is incorporated into organic compounds mainly by glutamine synthase activity. Thus, urease is involved in N remobilization, as well as in primary N assimilation. A previous study was performed by our team aiming to overexpress Eu4 gene in soybean plants. Unexpectedly, the transgenic plants exhibited endogenous (for all three genes) and introduced Eu4 transgene co-suppression and decreased ureolytic activity. Here, we sought to determine urease roles in soybean development by silencing all urease isoforms. Analyses were performed using transgenic co-suppressed and mutant plants. Plant development was evaluated 7, 14, 21 and 30 days after sowing. The cosuppressed plants presented a developmental delay during the first month after germination when compared with control. A slower development was observed for the double eu1-a/eu4-a mutant and the eu3-a (this gene codify an inactive accessory protein) single mutant. The N uptake in transgenic plants was significantly lower than that captured by non-transgenic plants. Among mutants, eu3-a presented the lowest and eu1- a the highest N content. A significantly lower number of seeds was obtained for transgenic plants. Altogether, these results indicate that the urease content and/or ureolytic activity play an important role in plant development. Soybeans (Glycine max) are affected by several abiotic and biotic stresses that limit the geographical distribution of cultures and lead to significant reductions in growth and productivity. In Brazil, the diseases caused by nematodes are one of the most damaging biotic stresses for soybeans.. The main species found in Brazil are Meloidogyne spp. (root-knot), Heterodera glycines (cyst), Pratylenchus brachyurus (root lesion) and Rotylenchulus reniformis (reniform). Root-knot and cyst nematodes (sedentary nematodes), the most damaging soybean pathogens, are very difficult to control. In this study, we identified a soybean urease-derived peptide (named Soyuretox) that exerts toxic effects against the root-knot phytonematode (M. javanica). Soyuretox was expressed in soybean roots of composite plants and complete stable transgenic plants. Roots of composite plants and stable transgenic plants overexpressing Soyuretox exhibited a significant reduction (50% and 37.5%, respectively) in the average number of nematodes and eggs when compared with non-transformed roots, 45 days after inoculation. This is the first report of nematode resistance caused by a urease-derived peptide. Soyuretox may represent a useful tool as a new and efficient alternative to control pests and diseases in economically important crops.

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Plasma glycan"

Dinopoulos, Argirios. Atypical Nonketotic Hyperglycinemia. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199972135.003.0030.

Full text

Abstract:

Nonketotic hyperglycinemia (NKH) or glycine encephalopathy (GE) is an autosomal recessive inborn error of glycine degradation due to a defect in the glycine cleavage system (GCS). Accumulation of glycine, particularly in the central nervous system, leads to a variety of neurological symptoms, which may be progressive in infants. Clinical symptoms in atypical NKH are heterogeneous and, according to the age of presentation, cases can be divided in three forms: neonatal, infantile, and late onset. Late-onset atypical cases display an intermittent or a chronic course and may become apparent in adulthood. Psychiatric symptoms are common, and diagnosis may be difficult due to the rarity of the disorder. The CSF/plasma glycine ratio is diagnostic but in atypical cases is usually lower than the diagnostic cut-point for classical NKH. Treatment consists of dietary measures, but no consistent outcomes have been reported.

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Plasma glycan"

Meer, G., M. Thielemans, I. L. Genderen, A. L. B. Helvoort, P. Bijl, and K. N. J. Burger. "Lipid Transport from the Golgi Complex to the Plasma Membrane of Epithelial Cells." In Glyco-and Cellbiology, 61–68. Berlin, Heidelberg: Springer Berlin Heidelberg, 1994. http://dx.doi.org/10.1007/978-3-642-78729-4_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Mubaiwa, Tsitsi D., Lauren E. Hartley-Tassell, Evgeny A. Semchenko, Christopher J. Day, Michael P. Jennings, and Kate L. Seib. "Investigation of Whole Cell Meningococcal Glycan Interactions Using High Throughput Glycobiology Techniques: Glycan Array and Surface Plasmon Resonance." In Methods in Molecular Biology, 113–21. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9202-7_8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Pan, Chang Jiang, Jin Wang, H. Sun, and Nan Huang. "Hemocompatibility of PET (Polyethylene Terephthalate) Films Grafted PEG (Polyethylene Glycol) by Plasma Surface Modification." In Advanced Biomaterials VI, 339–42. Stafa: Trans Tech Publications Ltd., 2005. http://dx.doi.org/10.4028/0-87849-967-9.339.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Kravets, Vira, and Anatoliy Pinchuk. "Surface Plasmon Enhanced Fluorescence of Glycine-Dimer-Functionalized Silver Nanoparticles." In NATO Science for Peace and Security Series B: Physics and Biophysics, 405–10. Dordrecht: Springer Netherlands, 2017. http://dx.doi.org/10.1007/978-94-024-0850-8_20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Rizzo, V., and G. V. Melzi d’Eril. "Determination of Free 3-Methoxy-4-Hydroxyphenylethylene Glycol in Human Plasma and Cerebrospinal Fluid by HPLC with Electrochemical Detection." In Developments in Analytical Methods in Pharmaceutical, Biomedical, and Forensic Sciences, 271–77. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4899-3526-7_30.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Saifer, Mark G. P., Ralph Somack, and L. David Williams. "Plasma Clearance and Immunologic Properties of Long-Acting Superoxide Dismutase Prepared Using 35,000 to 120,000 Dalton Poly-Ethylene Glycol." In Free Radicals in Diagnostic Medicine, 377–87. Boston, MA: Springer US, 1994. http://dx.doi.org/10.1007/978-1-4615-1833-4_26.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Suzuki, Kenichi G. N., Hiromune Ando, Naoko Komura, Miku Konishi, Akihiro Imamura, Hideharu Ishida, Makoto Kiso, Takahiro K. Fujiwara, and Akihiro Kusumi. "Revealing the Raft Domain Organization in the Plasma Membrane by Single-Molecule Imaging of Fluorescent Ganglioside Analogs." In Chemical Glycobiology Part B. Monitoring Glycans and their Interactions, 267–82. Elsevier, 2018. http://dx.doi.org/10.1016/bs.mie.2017.06.038.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Sato, Chihiro, Nao Yamakawa, and Ken Kitajima. "Measurement of Glycan-Based Interactions by Frontal Affinity Chromatography and Surface Plasmon Resonance." In Methods in Enzymology, 219–32. Elsevier, 2010. http://dx.doi.org/10.1016/s0076-6879(10)78010-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

White, Gilbert C., Harold R. Roberts, and Nigel S. Key. "The biology of haemostasis and thrombosis." In Oxford Textbook of Medicine, edited by Chris Hatton and Deborah Hay, 5490–509. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198746690.003.0543.

Full text

Abstract:

Haemostasis—a component of the wound defence mechanism—is a process by which vessel wall components and platelets act in concert with procoagulant and anticoagulant proteins to form a plug of cells and cross-linked fibrin. The plug is later remodelled and replaced by new tissue as part of wound healing. These processes are very complex and involve highly controlled pathways of interaction between cells, glycans, and membrane-bound and soluble proteins of coagulation and fibrinolysis, as well as their cognate inhibitors. Thrombosis—this is an abnormal state leading to formation of a clot that partially or completely obstructs the flow of blood within the blood vessel; dislodgement leads to thromboembolism. To understand the biology of haemostasis and thrombosis, it is necessary to know the roles of the vessel wall, the platelets, the coagulation and fibrinolytic systems, and their respective inhibitors. Fibrinolysis and coagulation are interrelated: fibrin clots are normally lysed by plasmin locally released from plasminogen by the action of tissue plasminogen activator, and this process can be enhanced by some procoagulant factors (e.g. activated factor XII, and protein C). This system, so delicately controlled and normally maintained in a dynamic equilibrium, is strongly influenced by components involved in inflammatory and other defence mechanisms in the host. An integrated understanding of these processes offers the potential for improved means to predict the adverse complications of many diseases and ultimately to prevent their occurrence.

APA, Harvard, Vancouver, ISO, and other styles

Pickart, Loren, and Steve Lovejoy. "[28] Biological activity of human plasma copper-binding growth factor glycyl-l-histidyl-l-lysine." In Peptide Growth Factors - Part B, 314–28. Elsevier, 1987. http://dx.doi.org/10.1016/0076-6879(87)47121-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Plasma glycan"

"Association between total plasma N-glycan levels and chronic back pain: a prospective study." In Bioinformatics of Genome Regulation and Structure/ Systems Biology. institute of cytology and genetics siberian branch of the russian academy of science, Novosibirsk State University, 2020. http://dx.doi.org/10.18699/bgrs/sb-2020-266.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Kim, Hyesook, Julia Matzenbacher Santos, Aby Joiakim, David Kaplan, Ben Rybicki, Alan Dombkowski, and David A. Putt. "Abstract 690: Improvement of prostate cancer diagnosis using a multiplex test of PSA, GDF-15 (NAG-1) and glycan-binding auto-IgG in plasma." In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-690.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Pedrow, Patrick, Ibrahim Alhamarneh, and Steven Goheen. "Plasma-assisted Grafting of Polyethylene Glycol (PEG) to Solid Substrates." In 2007 IEEE Pulsed Power Plasma Science Conference. IEEE, 2007. http://dx.doi.org/10.1109/ppps.2007.4345870.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Zhao, Tianying, Jingjing Zhu, and Lang Wu. "Abstract 3519: Genetically predicted plasma N-glycans and prostate cancer risk: Analysis of over 140,000 European descendants." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-3519.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Mahmoud, Mohamed, Ahmed Alsalman, and Hassan Almalki. "Novel Sample Pretreatment to Determine Iron Counts in Sour Glycol Streams by Spectrophotometer." In International Petroleum Technology Conference. IPTC, 2021. http://dx.doi.org/10.2523/iptc-21372-ms.

Full text

Abstract:

Abstract Determination of Iron Content in Triethylene glycol (TEG) samples is a very important indicator in measuring the system corrosion rate in oil and gas facilities. This study employed the application of an alternative/easy and reliable test method, which involved the use of a spectrophotometer for quantification of Iron concentration in tri ethylene glycol samples, that are used in sour gas dehydration units, rather than the sophisticated technique of Inductively Coupled Plasma Optical Emission Spectroscopy, ICP-OES. The main challenge was how to eliminate/minimize the significant interference from the carryover condensate hydrocarbons, BTEX, H2S and amine additives, which cause either precipitation with spectrophotometer reagents or turbid samples. The sample pretreatment process included: 1 - Sample digestion with dilution to eliminate the dissolved acid gases and the dissolved BTEX from the sample in acidic medium; 2 - pH adjustment from 9 – 10.5 to eliminate the amine additives interference with spectrophotometer reagents and 3 – Application of standard addition technique with certified reference material for iron with dilution, to reach the spectrophotometer detection limit and give intense color with more UV absorbance. The method was validated against ICP-OES and the results variance were within 10% acceptance criteria.

APA, Harvard, Vancouver, ISO, and other styles

Miekka, Shirley I. "USE OF ALBUMIN AND TWEEN AS STABILIZERS TO PREVENT ACTIVITY LOSS DURING CLOTTING ASSAYS OF COAGULATION FACTOR IX AND X CONCENTRATES." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644065.

Full text

Abstract:

Assays for clotting activities of Vitamin K-dependent coagulation factors in Factor IX complex concentrates are IcnovTn to give variable results depending on the composition of the sample diluent. Higher potency values are obtained when deficient plasma is used for sample pre-dilution compared with dilution in buffer. This discrepancy is more pronounced in assays of higher purity Factor IX (FIX) or Factor X (FX) concentrates. We have found that addition of a mixture of bovine albumin (0.1% w/v) and Tween 20 (0.01% v/v) (BAT) to the dilution buffer can eliminate the discrepancy, giving clotting times and plot slopes equal to chose obtained upon dilution in deficient plasma. Less protection was obtained with either albumin or Tween added separately. Polyethylene glycol 8000 (0.1% w/v), commonly used to stabilize thrombin solutions, gave variable results. BAT had no effect on clotting times of whole plasma or of FIX or FX samples pre-diluted in deficient plasma. Neither deficient plasma nor BAT had any effect when added after sample dilutions were prepared: activity of a FIX concentrate was 137 U/ml when pre-diluted in Factor IX-deficient plasma and 1312 U/ml diluted in BAT, compared with 49 U/ml diluted in buffer alcne; addition of deficient plasma or BAT to the dilutions of sample in buffer gave activities of only 36 a).id 34 U/ml, respectively. Similar results were obtained with FX samples. Furthermore, when a solution of FX (pre-diluted to 1 U/ml in buffer without stabilizer) was merely transferred from one test tube to another without further dilution, clotting times increased progressively and activity decreased by 85% after 8 transfers. By contrast, an identical sample diluted to 1 U/ml with BAT remained essentially unchanged after 8 serial transfers. These results indicate that Vitamin K-dependent coagulation factors are very susceptible to surface adsorption or inactivation after dilution of concentrates, and that either BAT or deficient plasma will prevent this loss. The use of albumin and Tween as stabilizers provides a simpler, .less expensive alternative to prevent nonspecific surface adsorption and achieve more accurate measurement of clotting activities.

APA, Harvard, Vancouver, ISO, and other styles

Müller, E., and A. Henschen. "HUMAN PLASMA FIBRINOGEN MOLECULAR WEIGHT VARIANTS:CHARACTERIZATION BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY AND IDENTIFICATION BY SEQUENCE ANALYSIS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643328.

Full text

Abstract:

Human plasma has been shown to contain several fibrinogen variants which differ from each other in molecular weight. The three most common forms, with molecular weights of 340 kD, 305 kD and 270 kD, have been reported to change considerably in their relative amounts during certain pathophysiological processes such as acute phase reactions, disseminated intravascular coagulation, fibrinolytic disorders, liver disease and cancer. Though it has been suggested that the differences in molecular weight are due to degradation of one or both, respectively, of the carboxy-terminal parts of the Aα-chains, the removed or altered segments have so far never been precisely determined. Consequently, it has only been possible to speculate about the origin of the variants.The aim of this study was to isolate the various molecular weight variants from plasma and to characterize their peptide chain components proteinchemically. Fibrinogen was first isolated from plasma by glycin precipitation and the variants were then separated by stepwise ammonium sulfate precipitation, taking advantage of their different solubility.The peptide chain components of the various fractions were isolated by reversed-phase high-performance liquid chromatography (HPLC). The N-termini were identified by direct sequence analysis. Chemical and enzymatic cleavages of the peptide chains resulted in fragment mixtures which were compared with the corresponding mixtures obtained from commercial fibrinogen by HPLC fingerprinting. Finally, the fragments which differed were identified by N-terminal sequence and amino acid analysis so that the exact C-termini of the peptide chains,especially in the lower molecular weight variants,could be determined. With the help of this information conclusions may also be drawn about the origin of the lower molecular weight variants and about the mechanism by which they may he formed.

APA, Harvard, Vancouver, ISO, and other styles

Lund-Hansen, T., and L. C. Peterson. "COMPARISON OF ENZYMATIC PROPERTIES OF HUMAN PLASMA FVIIa AND HUMAN RECOMBINANT FVIIa." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643787.

Full text

Abstract:

Human plasma FVIIa (pFVIIa) and human recombinant FVIIa (rFVIIa) were both purified by immune adsorption chromatography using a calcium dependent monoclonal antibody. The FVII obtained is highly purified and contains only trace contaminants as revealed by SDS-PAGE and reverse phase HPLC chromatography. FVII was fully activated during the purification procedure. A FVIIa activity assay has been developed in microplates using human FX as a substrate and methoxycarbonyl-D-cyclohexal-alanyl-glycyl-arginine-pNA as a chromogenic substrate for the FXa generated. The assay was linear at FVIIa concentrations between 0.5 and 10 nM. The concentration of the chromogenic substrate was 0.5 mM. A pH optimum at about 8 was found. An apparent Km=0.2 μM for FX was found for both pFVIIa and rFVIIa.The results suggest that the kinetics of human FX activation by pFVIIa and rFVIIa are identical. The FVIIa activity was found to be calcium dependent with maximal activity at about 0.25 mM, while the activities at 1 and 2 mM were 20% and 3%, respectively. When rabbit brain extract is used, the well-known dramatic enhancement effect of thromboplastin could be demonstrated with both FVII preparations. Also this reaction is calcium-dependent; however, the profile of the curve is distinctly different. Poly-D-lysine (MW 160,000) was found to enhance the FVIIa activity in a concentration dependent manner. Maximum stimulation (fivefold) was obtained at a concentration of about 10 mg/l.

APA, Harvard, Vancouver, ISO, and other styles

Toti, F., A. Stierlé, M. L. Wiesel, A. Schwartz, J. M. Freyssinet, and J. P. Cazenave. "PRODUCTION OF ANTIBODIES TO HUMAN VON WILLEBRAND FACTOR IN LAYING HENS. ISOLATION OF IMMUNOGLOBULINS AND APPLICATIONS TO THE DETECTION OF MOLECULAR DEFECTS OF VON WILLEBRAND FACTOR." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644084.

Full text

Abstract:

Von Willebrand disease (vWD) is an inherited disorder of primary hemostasis caused by deficiency or structural abnormalities of von Willebrand factor (vWF). VWF circulates in plasma and is also present in platelets. Plasma vWF, the carrier protein for factor VIII, is a large multimeric glycoprotein composed of identical subunits linked by disulfide bridges. Plasma and platelet vWF display distinct multimeric electrophoretic patterns. The different vWD subtypes can be classified either by the determination of vWFantigen (vWFíAg) and/or by multimer distribution. Antibodies to human vWF were raised in laying hens by intramuscular injections of purified human vWF. Immunoglobulins were isolated from egg yolks by selective polyethylene glycol and ammonium sulfate precipitations. These antibodies appeared to be monospecific, as they did not react with the plasma proteins of a patient with severe vWD. The pullets received weekly 50 μg vWF for 4 weeks and then had monthly injections. The antibodies occurred as early as the third injection, the yield being 300 to 500 mg of immunoglobulin per week (6-7 eggs). The titre could be constant over periods greater than 1 year. These immunoglobulins to vWF were tested in vWFíAg electroimmunoassays and for the multimer analysis of plasma and platelet vWF by electrophoresis and immunoblotting techniques. In no case could a difference be detected between assays performed with rabbit monospecific antiserum or with yolk immunoglobulins to human vWF. Ten to 12 multimers could be revealed for normal plasma vWF and up to 12 to 14 bands for normal platelet vWF (1.7% agarose). In the case of vWD, the electrophoresis patterns were identical with both antibodies. Thus, antibodies to vWF raised in laying hens are a suitable tool to detect and to characterize vWD. Although they do not interact with protein A, yolk antibodies are certainly advantageous to produce, as they do not contain IgM or IgA. Immunoglobulin fractions can contain up to 10 % of specific antibodies. Since they are available in larger quantities and are easy to isolate, larger homogeneous batches of antibodies can be obtained. This method may easily be applied to develop antibodies to a variety of antigens.

APA, Harvard, Vancouver, ISO, and other styles

Alvarez-Gonzalez, MA, A. Repici, H. Thompson, S. Mokashi, and C. Hassan. "PLASMA ELECTROLYTE CONCENTRATIONS AFTER THE USE OF 1L POLYETHYLENE GLYCOL BOWEL PREPARATION NER1006: POST HOC ANALYSIS OF RANDOMISED CLINICAL TRIALS." In ESGE Days 2019. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1681381.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

Contents

Academic literature on the topic 'Plasma glycan'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Journal articles on the topic "Plasma glycan"

Dissertations / Theses on the topic "Plasma glycan"

Books on the topic "Plasma glycan"

Book chapters on the topic "Plasma glycan"

Conference papers on the topic "Plasma glycan"